ADAGE CAPITAL PARTNERS GP, L.L.C.

Company

Tempest Therapeutics, Inc.

Filed

March 21, 2014

Accession Number

0000902664-14-001923

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →